Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

Wendy Deenik; Berna Beverloo; SCPAM van der Poel-va Luytgaarde; Moniek Wattel; JWJ Esser; Peter Valk; Jan Cornelissen

doi:10.1038/leu.2008.318

Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

Wendy Deenik, Berna Beverloo, SCPAM van der Poel-va Luytgaarde, Moniek Wattel, JWJ Esser, Peter Valk, Jan Cornelissen

Research output: Contribution to journal › Article › Academic › peer-review

72 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	627-629
Number of pages	3
Journal	Leukemia
Volume	23
Issue number	3
DOIs	https://doi.org/10.1038/leu.2008.318
Publication status	Published - 2009

Research programs

EMC MGC-02-96-01
EMC MM-02-41-03

Access to Document

10.1038/leu.2008.318

http://hdl.handle.net/1765/18112

Cite this

@article{366e8e85b0c44eb892fd1e2d6f4394ca,

title = "Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia",

author = "Wendy Deenik and Berna Beverloo and {van der Poel-va Luytgaarde}, SCPAM and Moniek Wattel and JWJ Esser and Peter Valk and Jan Cornelissen",

year = "2009",

doi = "10.1038/leu.2008.318",

language = "Undefined/Unknown",

volume = "23",

pages = "627--629",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

AU - Deenik, Wendy

AU - Beverloo, Berna

AU - van der Poel-va Luytgaarde, SCPAM

AU - Wattel, Moniek

AU - Esser, JWJ

AU - Valk, Peter

AU - Cornelissen, Jan

PY - 2009

Y1 - 2009

U2 - 10.1038/leu.2008.318

DO - 10.1038/leu.2008.318

M3 - Article

SN - 0887-6924

VL - 23

SP - 627

EP - 629

JO - Leukemia

JF - Leukemia

IS - 3

ER -